Response to Letter to the Editor: "18FDG-PET/CT Imaging in Breast Cancer Patients with Clinical Stage IIB or Higher"

被引：7
|
作者：
Srour, Marissa K. [1 ]
Amersi, Farin [1 ]
机构：
[1] Cedars Sinai Med Ctr, Div Surg Oncol, Dept Surg, Los Angeles, CA 90048 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / 05期
关键词：
PET/CT;
D O I：
10.1245/s10434-019-08194-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1710 / 1711
页数：2
相关论文
共 50 条
  • [1] Response to Letter to the Editor: “18FDG-PET/CT Imaging in Breast Cancer Patients with Clinical Stage IIB or Higher”
    Marissa K. Srour
    Farin Amersi
    Annals of Surgical Oncology, 2020, 27 : 1710 - 1711
  • [2] 18FDG-PET/CT Imaging in Breast Cancer Patients with Clinical Stage IIB or Higher Commentary on "Overuse of Preoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer" by Marissa K. Srour et al.
    Groheux, David
    Hindie, Elif
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (05) : 1708 - 1709
  • [3] 18FDG-PET/CT Imaging in Breast Cancer Patients with Clinical Stage IIB or HigherCommentary on “Overuse of Preoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer” by Marissa K. Srour et al.
    David Groheux
    Elif Hindié
    Annals of Surgical Oncology, 2020, 27 : 1708 - 1709
  • [4] Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer
    Groheux, David
    Hindie, Elif
    Delord, Marc
    Giacchetti, Sylvie
    Hamy, Anne-sophie
    de Bazelaire, Cedric
    de Roquancourt, Anne
    Vercellino, Laetitia
    Toubert, Marie-Elisabeth
    Merlet, Pascal
    Espie, Marc
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (24): : 1879 - 1887
  • [5] The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, IIIA primary operable breast cancer
    Groheux, D.
    Giacchetti, S.
    Espie, M.
    Vercellino, L.
    Hamy, A.
    Delord, M.
    Berenger, N.
    Toubert, M.
    Misset, J.
    Hindie, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S230 - S230
  • [6] The Yield of 18F-FDG PET/CT in Patients with Clinical Stage IIA, IIB, or IIIA Breast Cancer: A Prospective Study
    Groheux, David
    Giacchetti, Sylvie
    Espie, Marc
    Vercellino, Laetitia
    Hamy, Anne-Sophie
    Delord, Marc
    Berenger, Nathalie
    Toubert, Marie-Elisabeth
    Misset, Jean-Louis
    Hindie, Elif
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (10) : 1526 - 1534
  • [7] DOES 18FDG-PET/CT MODIFY THE TREATMENT STRATEGY IN STAGE I-III BREAST CANCER PATIENTS?
    Valli, M. C.
    Fozza, A.
    Pesce, G.
    Azinwi, N. C.
    Martucci, F.
    Ceriani, L.
    Richetti, A.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S234 - S234
  • [8] Effect of 18F-FDG PET/CT imaging in patients with clinical stage II and III breast cancer
    Groheux, David
    Moretti, Jean-Luc
    Baillet, Georges
    Espie, Marc
    Giacchetti, Sylvff
    Hindie, Elff
    Hennequin, Christophe
    Vilcoq, Jacques-Robert
    Cuvier, Caroline
    Toubert, Marie-Elisabeth
    Filmont, Jean-Emmanuel
    Sarandi, Farid
    Misset, Jean-Louis
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (03): : 695 - 704
  • [9] Does 18FDG-PET/CT modify the treatment strategy in stage I-III breast cancer patients?
    Valli, M.
    Fozza, A.
    Martucci, F.
    Azinwi, C. N.
    Pesce, G.
    Ceriani, L.
    Richetti, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (09) : 602 - 602
  • [10] Dual-phase, 18FDG-PET/CT imaging in patients with various cancer types
    Drougas, D.
    Giannopoulou, C.
    Panagiotidis, E.
    Skilakaki, M.
    Rondogianni, P.
    Vlontzou, E.
    Chousianakou, E.
    Datseris, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S278 - S278
12345